The global metabolomics market is expected to reach US$ 2 billion by 2024, registering a compound annual growth rate (CAGR) of 17.10% during the forecast period. The growing demand for personalized medicine, increasing use of metabolomics in toxicology testing, and availability of government and private funding are driving the market. In addition, the increasing R&D expenditure on pharmaceutical and biotech and technological advancements are expected to fuel the growth of the market. However, the issues related to data examination and processing and the high cost of tools and instruments are hampering the growth of the market.
In this report, the global metabolomics market is segmented by technique, application, indication, and region. On the basis of technique, the market is segmented into separation techniques, such as gas chromatography, capillary electrophoresis, high-performance liquid chromatography, and ultra performance liquid chromatography; and detection techniques, such as nuclear magnetic resonance spectroscopy, mass spectrometry, and surface based mass analysis. The market on the basis of application is segmented into biomarker discovery, drug discovery/drug assessment toxicology testing, nutrigenomics, and others. The market by indication is segmented into oncology, neurology, cardiology, and others.
The global metabolomics market is segmented on the basis of key regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America accounted for the largest share of 45% of the metabolomics market in 2014. The market in Asia Pacific is projected to grow at a CAGR of 24% during the forecast period. Increasing penetration of pharmaceutical products is stimulating the growth of the market in Asia Pacific. Furthermore, each region is segmented to provide market revenue for select countries such as the U.S., Canada, the U.K., Germany, China, Japan, India, Russia, Brazil, and GCC countries. The report includes a detailed study of the global and regional metabolomics market and analyzes the variations in the growth of the industry in certain regions.
A glimpse of the report structure is provided in the report description available on the website.
Thermo Fisher Scientific Inc., Danaher Corporation, Waters Corporation, Agilent Technologies, Metabolon, Inc., Shimadzu Corporation, Bruker Corporation, and Biocrates Life Sciences AG are the most active players in the metabolomics market.
This report covers the metabolomics market, in terms of value, and forecasts the market size till 2024. In addition, the report identifies key growth segments and opportunities in the industry. This report also covers detailed competitive outlook including the share and company profiles of the key players in the global market. Company profile includes company summary, financial summary, business strategy and planning, SWOT analysis, and current developments.
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact firstname.lastname@example.org